Is glenmarkpharma.ca Safe? Security Analysis for Glenmark Pharmaceuticals
https://glenmarkpharma.caCheck if glenmarkpharma.ca is a scam or legitimate. Free security scan and reviews.
Below Healthcare avg (65)
10,000+
Domains scanned
500+
Security teams trust us
EveryPay
Secure checkout
Instant
Reports delivered
Get the professional PDF report for glenmarkpharma.ca
Export this security analysis as a professional PDF document, receive it via email, and access marketing intelligence data including contact emails and phone numbers. One-time purchase for lifetime access.
PDF Report & Export
PDF download, email delivery, unlock code
Marketing Intelligence
Contact emails, phone numbers & warm leads
Plan Comparison
| Feature | PDF Report | Marketing+ |
|---|---|---|
| Full security analysis | ||
| Professional PDF export | ||
| Email delivery | ||
| Lifetime access + unlock code | ||
| Contact emails & phones | — | |
| Marketing outreach data | — |
Already purchased?
Order summary
Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.
Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.
SEQ SIA
Lastadijas 12 k-3, Riga, Latvia, LV-1050
Reg. No. 40203410806 • VAT LV40203410806
Support: guard@offseq.com • +371 2256 5353
AI Summary
Glenmark Pharmaceuticals Ltd. operates a Canadian website providing pharmaceutical products and patient resources, focusing on generic drugs. The company is part of a global pharmaceutical group with a presence in multiple countries including the US and India. The website is built on WordPress with a modern tech stack including Google Analytics and Tag Manager for tracking. The site is professionally designed with good navigation and mobile optimization, targeting patients and healthcare professionals in Canada. Security posture is adequate with HTTPS enforced and domain transfer protection, but lacks DNSSEC and explicit security policies. Privacy compliance is limited due to absence of cookie consent mechanisms and detailed privacy policies. Overall, the website reflects a credible and established pharmaceutical business with room for improvement in security and privacy transparency.
Detected Technologies
10 urgent findings need attention
10 high
- + 2 more findings in the full report below
Keep glenmarkpharma.ca under constant watch
Guard tracks your live infrastructure daily: certificate expiry, DNS & mail authentication drift, uptime changes, subdomain inventory, and unexpected tracker or content shifts. A full timeline captures every diff so you can prove remediation and spot regressions instantly.
Security drift alerts
Risk score drops, new high-severity issues, and header hardening gaps
Compliance watch
GDPR / NIS2 posture changes with governance evidence snapshots
Infrastructure surface
Unexpected open services, SSL expiry, DNS & email authentication changes
Content & tracker intelligence
Marketing tech shifts, analytics drift, and AI recommendation updates
Cancel anytime. Alerts sent to the contacts you choose. Unlock the full report to view historical timelines and alerts.
Security Headers
6 findings
45/100
GDPR Compliance
4 findings
53/100
NIS2 Compliance
9 findings
2/100
Email Security
4 findings
70/100
🧠AI Business Intelligence
Technology stack, business insights, and market analysis powered by AI.
Business Intelligence
Market & Strategic Analysis
The company holds a strong market position as a global pharmaceutical manufacturer with a dedicated Canadian presence. Its business model centers on manufacturing and distributing generic pharmaceutical products. The website supports patient engagement through adverse event reporting and educational content. The absence of direct contact emails or phone numbers on the homepage suggests a controlled communication channel, likely via contact forms. The company leverages partnerships and subsidiaries to extend its market reach. The digital presence is mature but could enhance compliance and security disclosures to align with industry best practices.
Security Posture Analysis
Comprehensive Security Assessment
The website employs HTTPS with a valid SSL certificate and domain transfer protection, indicating a baseline security posture. However, the lack of DNSSEC implementation and missing security headers reduce the overall security robustness. No explicit incident response or security policies are published, which may impact trust and compliance. The use of third-party analytics introduces moderate user tracking, but an opt-out mechanism is present. No critical vulnerabilities or exposed sensitive data were detected in the analysis. Recommendations include enabling DNSSEC, adding security headers, and publishing security and incident response policies to improve security maturity.
Strategic Recommendations
Priority Actions for Security Improvement
Enable DNSSEC on the domain to protect against DNS spoofing and improve domain security.
✨Observations
AI-powered comprehensive website and business analysis.
AI-Enhanced Website Analysis
Business Insights
Glenmark Pharmaceuticals
Glenmark Pharmaceuticals Ltd. operates in Canada providing pharmaceutical products including generic drugs. The website offers information about the company, its leadership, products, patient resources, and contact details.
good
consistent
Technical Stack
moderate
good
basic
good
Security Assessment
- HTTPS enforced
- ClientTransferProhibited domain status
Analytics & Tracking
Advertising & Marketing
Website Quality Assessment
Key Observations
Website is a WordPress-based pharmaceutical company site for Canadian market.
Get this report delivered to your inbox
Receive a summary of the glenmarkpharma.ca security findings by email. Quick and easy to share with decision makers.
🛡️Security Headers
HTTP security headers analysis and recommendations.
Security Headers
HTTP security headers analysis
Missing X-Frame-Options header
HIGHPrevents clickjacking attacks
Missing Content-Security-Policy header
HIGHControls resources the browser is allowed to load
Weak X-XSS-Protection configuration
LOWCurrent value: "1"
Weak Referrer-Policy configuration
LOWCurrent value: "no-referrer-when-downgrade"
Missing Permissions-Policy header
MEDIUMControls browser features and APIs
Sensitive data may be cached
LOWCache-Control header should include "no-store" for sensitive pages
👤GDPR Compliance
Privacy and data protection assessment under GDPR regulations.
GDPR Compliance
Privacy and data protection assessment
No Cookie Policy found
HIGHGDPR requires clear information about cookie usage
No Cookie Consent Banner found
HIGHGDPR requires explicit consent for non-essential cookies
No Data Protection Officer mentioned
LOWLarge organizations may need to designate a DPO under GDPR
Privacy policy may not be GDPR compliant
MEDIUMPrivacy policy lacks explicit GDPR compliance elements
GDPR Compliance Analysis
🛡️NIS2 Compliance
Network & Information Security Directive compliance assessment.
NIS2 Compliance
Network & Information Security Directive
No information security framework found
HIGHNIS2 requires documented cybersecurity and information security measures
No vulnerability disclosure policy
MEDIUMNIS2 encourages coordinated vulnerability disclosure
No security policy documentation found
HIGHNIS2 requires documented cybersecurity governance and risk management
No incident response procedures found
HIGHNIS2 requires documented incident response and business continuity plans
No business continuity planning found
MEDIUMNIS2 emphasizes operational resilience and business continuity
No security contact information
HIGHNIS2 requires clear incident reporting channels
No vulnerability reporting mechanism
MEDIUMClear vulnerability reporting supports coordinated disclosure
No NIS2 reference found
LOWConsider explicitly mentioning NIS2 compliance efforts
Critical sector without clear security compliance
HIGHDetected sectors: transport, banking, health, digital
Need this report as a PDF?
Download the complete glenmarkpharma.ca security analysis as a professional PDF. Share it with your team, clients, or stakeholders.
📧Email Security
SPF, DKIM, and DMARC validation and email security assessment.
Email Security
SPF, DKIM, and DMARC validation
No DKIM record found
MEDIUMDKIM adds cryptographic signatures to emails
No BIMI Record
LOWBIMI displays brand logos in email clients
No MTA-STS Policy
MEDIUMMTA-STS enforces TLS for email delivery
No TLS-RPT Record
LOWTLS-RPT provides reporting for email TLS issues
SPF Details
🏆SSL/TLS Security
Certificate validity and encryption analysis.
SSL/TLS Security
Certificate validity and encryption analysis
Weak Protocols Supported
HIGHServer supports weak protocols: TLSv1.1
OCSP Stapling Not Enabled
LOWOCSP stapling improves performance and privacy
Certificate Transparency Not Implemented
LOWCertificate is not logged in Certificate Transparency logs
SSL Certificate Expires Within 90 Days
MEDIUMSSL certificate expires in 79 days
Mixed Content Detected
MEDIUM1 resources loaded over insecure HTTP
Partial SSL/TLS Assessment
LOWCompleted 3 of 4 security checks due to time constraints
Protocol Support
OCSP Status
📊DNS Health
DNS configuration and security assessment.
DNS Health
DNS configuration and security assessment
DNSSEC Not Enabled
MEDIUMDNSSEC is not configured for this domain
CAA Records Not Configured
LOWCertificate Authority Authorization (CAA) records not found
Domain Delete Lock Not Enabled
LOWDomain can be deleted without additional verification
No DMARC Record
MEDIUMDMARC policy not configured
Domain Registration Details
DNS Records
DNSSEC Status
DNS Performance
SPF Analysis
⚡Network Security
Port scanning and network exposure analysis.
Network Security
Port scanning and network exposure analysis
Good Network Security Posture
LOWNo unnecessary services detected on common risky ports
How does glenmarkpharma.ca compare?
See how glenmarkpharma.ca stacks up against similar websites in the same industry.
🔧Technical Analysis
Detailed technical findings and analysis from AI assessment.
Technical Analysis
Comprehensive security assessment findings
Additional Findings
Download the glenmarkpharma.ca report as PDF
Get the complete analysis in a shareable PDF format, delivered instantly to your email with lifetime access.
PDF Report & Export
PDF download, email delivery, unlock code
Marketing Intelligence
Contact emails, phone numbers & warm leads
Plan Comparison
| Feature | PDF Report | Marketing+ |
|---|---|---|
| Full security analysis | ||
| Professional PDF export | ||
| Email delivery | ||
| Lifetime access + unlock code | ||
| Contact emails & phones | — | |
| Marketing outreach data | — |
Already purchased?
Order summary
Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.
Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.
SEQ SIA
Lastadijas 12 k-3, Riga, Latvia, LV-1050
Reg. No. 40203410806 • VAT LV40203410806
Support: guard@offseq.com • +371 2256 5353
Scan your own website
Liked the glenmarkpharma.ca report? Run the same comprehensive security analysis on your domain — free, instant, and no sign-up required.
Or browse our directory of >10,000 scanned websites.
How did we do?
Your feedback directly shapes our roadmap. Rate the quality of this report, leave an optional comment, and let us know if you want our security specialists to follow up.
What others say about glenmarkpharma.ca
Share your experience to help others make informed decisions. We verify every review by email and publish it once our moderation team approves it.
Community rating
—out of 5
0 reviews published